Literature DB >> 1905921

Purification and properties of a neurotensin-degrading endopeptidase from pig brain.

P E Millican1, A J Kenny, A J Turner.   

Abstract

Neurotensin (NT) endopeptidase (EC 3.4.24.16) has been purified about 800-fold from pig brain by four sequential chromatographic steps depending on ion-exchange and hydrophobic interactions. Two types of preparation were studied: one from a Triton X-100-solubilized membrane fraction, and the other from the soluble fraction containing 90% or more of the total activity in the homogenate. NT endopeptidase activity was monitored by high-precision liquid chromatography of the two peptide products, characterized as NT-(1-10) and NT-(1-8), resulting from cleavage of the Pro10-Tyr11 and Arg8-Arg9 bonds respectively. As purification proceeded, from both membranes and cytosol, the yield of the two products achieved a constant ratio of 5:1 and this ratio was reproduced in repeated purifications. However, a distinct peptidase which hydrolysed exclusively at the Arg8-Arg9 bond was partially resolved from NT endopeptidase by chromatography on hydroxyapatite, and this activity was further purified and assigned to endopeptidase-24.15 (EC 3.4.24.15). SDS/PAGE of both preparations of neurotensin endopeptidase revealed a major band of apparent Mr 75000, and treatment of the membrane-associated form with N-Glycanase gave no evidence that the enzyme was a glycoprotein. The membrane-associated and cytosol forms of NT endopeptidase activities, monitored for both NT-(1-10) and NT-(1-8) products, were compared in their responses to 1,10-phenanthroline, EDTA, dithiothreitol (DTT) and some synthetic site-directed inhibitors of endopeptidase-24.15 or peptidyl dipeptidase A. The effects revealed no significant differences between the two preparations, nor did the reagents discriminate between the activities generating the two NT fragments. The partially purified form of endopeptidase-24.15 was also included in this comparison: while some responses were similar, this peptidase was distinguishable in its activation by DTT and its relative resistance to inhibition by EDTA. Both forms of NT endopeptidase were found to hydrolyse other substrates, including Boc-Phe-Ala-Ala-Phe-4-aminobenzoate, bradykinin and substance P (these at faster rates than neurotensin), as well as dynorphin A-(1-8) and luliberin. The bonds hydrolysed in these neuropeptides, as well as in angiotensins I and II and alpha-neoendorphin, were defined. These studies confirm that NT endopeptidase is distinct from endopeptidase-24.15. They further show that the former is a soluble enzyme, not an integral membrane protein, that it is not peptide-specific and that it might be more appropriately named. enzyme, not an integral membrane protein, that it is not peptide-specific and

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1905921      PMCID: PMC1151045          DOI: 10.1042/bj2760583

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

1.  Soluble metalloendopeptidase from rat brain: action on enkephalin-containing peptides and other bioactive peptides.

Authors:  T G Chu; M Orlowski
Journal:  Endocrinology       Date:  1985-04       Impact factor: 4.736

2.  Thiol-dependent metallo-endopeptidase characteristics of Pz-peptidase in rat and rabbit.

Authors:  U Tisljar; A J Barrett
Journal:  Biochem J       Date:  1990-04-15       Impact factor: 3.857

3.  Inactivation of neurotensin by rat brain synaptic membranes. Cleavage at the Pro10-Tyr11 bond by endopeptidase 24.11 (enkephalinase) and a peptidase different from proline-endopeptidase.

Authors:  F Checler; P C Emson; J P Vincent; P Kitabgi
Journal:  J Neurochem       Date:  1984-11       Impact factor: 5.372

4.  Active site directed N-carboxymethyl peptide inhibitors of a soluble metalloendopeptidase from rat brain.

Authors:  T G Chu; M Orlowski
Journal:  Biochemistry       Date:  1984-07-31       Impact factor: 3.162

5.  Purification and characterization of a novel neurotensin-degrading peptidase from rat brain synaptic membranes.

Authors:  F Checler; J P Vincent; P Kitabgi
Journal:  J Biol Chem       Date:  1986-08-25       Impact factor: 5.157

6.  Inactivation of neurotensin by rat brain synaptic membranes partly occurs through cleavage at the Arg8-Arg9 peptide bond by a metalloendopeptidase.

Authors:  F Checler; J P Vincent; P Kitabgi
Journal:  J Neurochem       Date:  1985-11       Impact factor: 5.372

7.  Naloxone-insensitive potentiation of neurotensin hypothermic effect by the enkephalinase inhibitor thiorphan.

Authors:  A Coquerel; I Dubuc; J F Menard; P Kitabgi; J Costentin
Journal:  Brain Res       Date:  1986-11-29       Impact factor: 3.252

8.  Mechanism of neurotensin degradation by rat brain peptidases.

Authors:  J R McDermott; A I Smith; J A Edwardson; E C Griffiths
Journal:  Regul Pept       Date:  1982-05

9.  Brain endo-oligopeptidase A, a putative enkephalin converting enzyme.

Authors:  A C Camargo; E B Oliveira; O Toffoletto; K M Metters; J Rossier
Journal:  J Neurochem       Date:  1987-04       Impact factor: 5.372

10.  Substrate and inhibitor studies of thermolysin-like neutral metalloendopeptidase from kidney membrane fractions. Comparison with bacterial thermolysin.

Authors:  M Pozsgay; C Michaud; M Liebman; M Orlowski
Journal:  Biochemistry       Date:  1986-03-25       Impact factor: 3.162

View more
  8 in total

1.  Distinct properties of neuronal and astrocytic endopeptidase 3.4.24.16: a study on differentiation, subcellular distribution, and secretion processes.

Authors:  B Vincent; A Beaudet; P Dauch; J P Vincent; F Checler
Journal:  J Neurosci       Date:  1996-08-15       Impact factor: 6.167

2.  A Group of Weakly Bound to Neurons Extracellular Metallopeptidases (NEMPs).

Authors:  Ekaterina S Kropotova; Mark I Mosevitsky
Journal:  Neurochem Res       Date:  2016-06-27       Impact factor: 3.996

3.  Identification of membrane-bound variant of metalloendopeptidase neurolysin (EC 3.4.24.16) as the non-angiotensin type 1 (non-AT1), non-AT2 angiotensin binding site.

Authors:  Naomi J Wangler; Kira L Santos; Ines Schadock; Fred K Hagen; Emanuel Escher; Michael Bader; Robert C Speth; Vardan T Karamyan
Journal:  J Biol Chem       Date:  2011-10-28       Impact factor: 5.157

Review 4.  Neurolysin: From Initial Detection to Latest Advances.

Authors:  Frédéric Checler; Emer S Ferro
Journal:  Neurochem Res       Date:  2018-08-29       Impact factor: 3.996

5.  Neurotensin increases mortality and mast cells reduce neurotensin levels in a mouse model of sepsis.

Authors:  Adrian M Piliponsky; Ching-Cheng Chen; Toshihiko Nishimura; Martin Metz; Eon J Rios; Paul R Dobner; Etsuko Wada; Keiji Wada; Sherma Zacharias; Uma M Mohanasundaram; James D Faix; Magnus Abrink; Gunnar Pejler; Ronald G Pearl; Mindy Tsai; Stephen J Galli
Journal:  Nat Med       Date:  2008-03-30       Impact factor: 53.440

6.  Endopeptidase 3.4.24.11 converts N-1-(R,S)carboxy-3-phenylpropyl-Ala-Ala-Phe-p-carboxyanilide into a potent inhibitor of angiotensin-converting enzyme.

Authors:  C H Williams; T Yamamoto; D M Walsh; D Allsop
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

Review 7.  The metzincins--topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases.

Authors:  W Stöcker; F Grams; U Baumann; P Reinemer; F X Gomis-Rüth; D B McKay; W Bode
Journal:  Protein Sci       Date:  1995-05       Impact factor: 6.725

8.  Renin-angiotensin system gene expression and neurodegenerative diseases.

Authors:  Benjamin Goldstein; Robert C Speth; Malav Trivedi
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-09-09       Impact factor: 1.636

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.